ENGLE STEVEN B 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed May 25, 2004
Insider Transaction Report
Form 4
ENGLE STEVEN B
DirectorCEO & Chairman
Transactions
- Award
Stock Options (right to buy)
2004-05-21+300,000→ 300,000 totalExercise: $2.96Exp: 2014-05-21→ Common Stock (300,000 underlying)
Holdings
- 1,484
Common Stock
Footnotes (1)
- [F1]50% of the options vest on the date that the Company receives approval to market its lead drug candidate for the treatment of lupus and 1/24 of the remaining options vest at the end of each month thereafter until all of the options are vested. Notwithstanding the foregoing, if marketing approval is not obtained between the grant date and the three year anniversary of the grant date, then 100% of the options will vest on the three year anniversary of the grant date.